Company News: Page 27
Latest company news on US-listed stocks: earnings, guidance, deals, management changes and product announcements, linked to each ticker page.
Bull of the Day: Chevron (CVX)
Nasdaq
This oil major is pumping out cash, raising estimates and paying you to wait.
Bear of the Day: Southwest Airlines (LUV)
Nasdaq
Fuel prices are taking off, but this airline stock may not.
RenovoRx Enrolls First Patient In UVM-Sponsored Pancreatic Cancer PRISM-TAMP Trial
Nasdaq
(RTTNews) - RenovoRx, Inc. (RNXT), a life sciences company developing oncology therapies, has enrolled its first patient in PRISM-TAMP, "PDAC Regression and Intraoperative Surgical Margin With…
New Strong Buy Stocks for October 8th
Nasdaq
VIRT, SMCI, SM, E and INSW have been added to the Zacks Rank #1 (Strong Buy) List on October 8th, 2026.
New Strong Sell Stocks for October 8th
Nasdaq
AVNW, CYD and CIA have been added to the Zacks Rank #5 (Strong Sell) List on October 8th, 2026.
Russia's internet giant Yandex halts operations at major data center after drone attack
CNBC
Russian internet giant Yandex paused operations inside one of its data centers after a drone attack as Ukraine continues to hit the country's infrastructure.
Best Growth Stocks to Buy for October 8th
Nasdaq
ATI, BEKE and VLO made it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 8th, 2026.
Raymond James Upgrades Old National Bancorp - Preferred Stock to Outperform from Market Perform
Nasdaq
Fintel reports that on October 6, 2026, Raymond James upgraded their outlook for Old National Bancorp - Preferred Stock (NASDAQGS:ONBPP) from Market Perform to Outperform.Old National Bancorp, based…
The Zacks Analyst Blog Highlights Advanced Micro Devices, Palo Alto, CnocoPhillips and Iveda
Nasdaq
Advanced Micro Devices, Palo Alto, CnocoPhillips and Iveda are included in this Analyst Blog.
Argenx's Celiac Disease Phase 2 Study Meets Primary Endpoint; Discontinues Sjögren's UNITY Trial
Nasdaq
(RTTNews) - argenx SE (ARGX), an immunology company, on Thursday reported positive Phase 2 results for FB102 in celiac disease and separately announced that it will discontinue the Phase 3 UNITY…
Zacks Industry Outlook Anheuser-Busch InBev, Constellation Brands, Brown-Forman and Molson Coors
Nasdaq
Anheuser-Busch InBev, Constellation Brands, Brown-Forman and Molson Coors have been highlighted in this Industry Outlook article.
Zacks Industry Outlook Simon Property, Realty Income and Tanger
Nasdaq
Simon Property, Realty Income and Tanger have been highlighted in this Industry Outlook article.
Zacks.com featured highlights Seagate Technology, Western Digital and Dell
Nasdaq
Seagate Technology, Western Digital and Dell have been highlighted in this Screen of The Week article.
Zacks Earnings Trends Highlights: Micron, Nvidia, Alphabet, JPMorgan, Citigroup and Wells Fargo
Nasdaq
Micron, Nvidia, Alphabet, JPMorgan, Citigroup and Wells Fargo have been highlighted in this Earnings Trends article.
Value Line Tops Earnings, Extends Dividend Growth Streak to 12 Years
Nasdaq
Value Line (NASDAQ:VALU) reported higher earnings, increased retained earnings and a 12th consecutive annual dividend increase for its fiscal year ended April 30, 2026, Chairman and Chief Executive…
Argenx To Discontinue Phase 3 UNITY Study Of Efgartigimod In Sjgren's Disease
Nasdaq
(RTTNews) - argenx SE (ARGX) announced that it will discontinue the Phase 3 UNITY study of efgartigimod subcutaneous in adults with moderate-to-severe Sjgren's disease. Following interim analysis, an…
FDA Approves Pfizer's TUKYSA Regimen For Front-Line HER2+ Breast Cancer Maintenance
Nasdaq
(RTTNews) - Pfizer Inc. (PFE) announced that the U.S. Food and Drug Administration (FDA) approved TUKYSA in combination with trastuzumab and pertuzumab for maintenance treatment of adults with…
VTv's HPPD Receives FDA Orphan Drug Status For Sickle Cell Disease
Nasdaq
(RTTNews) - Wednesday, vTv Therapeutics Inc. (VTVT) said that the U.S. FDA granted Orphan Drug Status to HPPD (HPP8668) for the treatment of sickle cell disease.
Fresenius Medical Care Names Shervin Korangy CEO
Nasdaq
(RTTNews) - Fresenius Medical Care AG (FME.DE, FME) announced that Shervin J. Korangy will become Chief Executive Officer (CEO) and Chair of the Management Board, effective October 12, 2026. He will…
Here's Where Tesla and 4 Rival Automakers Could Be by 2030
Nasdaq
Key PointsBYD's overseas expansion is becoming a major growth engine.
Rally May Stall For Thai Stock Market
Nasdaq
(RTTNews) - The Thai stock market has tracked higher in five straight sessions, gathering almost 25 points or 1.6 percent in that span. The Stock Exchange of Thailand now sits just above the…
Citigroup Upgrades Flutter Entertainment to Buy from Neutral
Nasdaq
Fintel reports that on October 7, 2026, Citigroup upgraded their outlook for Flutter Entertainment (NYSE:FLUT) (DB:PPB) from Neutral to Buy. This rating action follows a prior upgrade by Citigroup on…
HSBC Initiates Coverage of Atour Lifestyle Holdings Limited - Depositary Receipt at Buy
Nasdaq
Fintel reports that on October 7, 2026, HSBC initiated coverage of Atour Lifestyle Holdings Limited - Depositary Receipt (NASDAQGS:ATAT) with a Buy recommendation. Atour Lifestyle Holdings Ltd is a…
Barclays Initiates Coverage of Boston Scientific with Equal-Weight
Nasdaq
Fintel reports that on October 7, 2026, Barclays initiated coverage of Boston Scientific (NYSE:BSX) (BATS-CHIXE:BSXD) with a Equal-Weight recommendation.Boston Scientific Corporation, based in the…
Headlines and summaries belong to their publishers; links open the original article on the publisher's site. MetaCap does not republish third-party articles.
Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer